From inflammation to lowering levels of the virus itself, a current study hopes to demystify pot's benefits for those living with HIV.

For too long, conducting legitimate research on the medical benefits of marijuana was all but impossible.

Kept out of the hands of doctors and scientists by an overzealous DEA, pot is still classified by the federal government as a Schedule I drug under the Controlled Substances Act—the strictest category available.

This makes funding and access to research-grade, federally legal cannabis hard to come by; even in states where marijuana is legal, studies on the drug are still subject to approval by multiple boards, and samples must be procured from the only lab in the country approved to dispense research-grade marijuana.

Click here to read the complete article

Steven Blum ~ Vice.com

 

Recent News Articles

Thursday July 18

First Ever Pot Cafe To Open In West Hollywood - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

The first ever cannabis cafe in the nation will open later this year in West…

327 hits

Thursday July 18

Ohio lawmakers vote to decriminalize CBD oil, hemp products - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

The Ohio House on Wednesday voted 88-3 in favor of legislation that would move Ohio…

674 hits

Thursday July 18

The marijuana industry needs innovation to thrive - Cannabis News

in Hi-Tech

by Bruce Kennedy - Editor in Chief

Marijuana companies are facing enormous pressure to innovate.

315 hits

Friday July 19

Louisiana 'weeks’ away from medical marijuana rollout - Cannabis News

in Law & Crime

by Bruce Kennedy - Editor in Chief

Medical marijuana could finally be available for Louisiana’s sickest patients in “the next few weeks,"…

288 hits

Friday July 19

Hype, Hops, and a Lot of Hope: Inside the Billion-Dollar Weed Drink Gamble - Cannabis…

in Finance

by Bruce Kennedy - Editor in Chief

With the exception of CBD, few cannabis products have received as much corporate hype as…

333 hits